nodes	percent_of_prediction	percent_of_DWPC	metapath
Epoprostenol—systemic scleroderma—Omeprazole—Barrett's esophagus	0.404	0.5	CpDpCtD
Epoprostenol—systemic scleroderma—Esomeprazole—Barrett's esophagus	0.404	0.5	CpDpCtD
Epoprostenol—CYP2C9—Omeprazole—Barrett's esophagus	0.0334	1	CbGbCtD
Epoprostenol—PTGIS—Synthesis of Prostaglandins (PG) and Thromboxanes (TX)—PTGES—Barrett's esophagus	0.0105	0.182	CbGpPWpGaD
Epoprostenol—PTGIS—Eicosanoid Synthesis—PTGES—Barrett's esophagus	0.0068	0.118	CbGpPWpGaD
Epoprostenol—PTGIS—Nicotinamide salvaging—PTGS2—Barrett's esophagus	0.00468	0.0812	CbGpPWpGaD
Epoprostenol—PTGIS—Arachidonic acid metabolism—PTGES—Barrett's esophagus	0.00378	0.0656	CbGpPWpGaD
Epoprostenol—PTGIS—smooth muscle tissue—Barrett's esophagus	0.0035	0.269	CbGeAlD
Epoprostenol—P2RY12—epithelium—Barrett's esophagus	0.00327	0.251	CbGeAlD
Epoprostenol—PTGIS—Nicotinate metabolism—PTGS2—Barrett's esophagus	0.00249	0.0432	CbGpPWpGaD
Epoprostenol—PTGIS—Cytochrome P450 - arranged by substrate type—CYP26A1—Barrett's esophagus	0.00247	0.0429	CbGpPWpGaD
Epoprostenol—Enlargement abdomen—Omeprazole—Barrett's esophagus	0.00221	0.0253	CcSEcCtD
Epoprostenol—Enlargement abdomen—Esomeprazole—Barrett's esophagus	0.00221	0.0253	CcSEcCtD
Epoprostenol—PTGIR—epithelium—Barrett's esophagus	0.00208	0.16	CbGeAlD
Epoprostenol—PTGIS—Synthesis of Prostaglandins (PG) and Thromboxanes (TX)—PTGS2—Barrett's esophagus	0.00205	0.0356	CbGpPWpGaD
Epoprostenol—PTGIR—smooth muscle tissue—Barrett's esophagus	0.00201	0.154	CbGeAlD
Epoprostenol—PTGIS—Phase 1 - Functionalization of compounds—CYP26A1—Barrett's esophagus	0.00201	0.0348	CbGpPWpGaD
Epoprostenol—PTGIR—digestive system—Barrett's esophagus	0.00159	0.122	CbGeAlD
Epoprostenol—PTGIS—Eicosanoid Synthesis—PTGS2—Barrett's esophagus	0.00133	0.0231	CbGpPWpGaD
Epoprostenol—PTGIS—Adipogenesis—CYP26A1—Barrett's esophagus	0.00133	0.0231	CbGpPWpGaD
Epoprostenol—Injection site reaction—Omeprazole—Barrett's esophagus	0.00132	0.0151	CcSEcCtD
Epoprostenol—Injection site reaction—Esomeprazole—Barrett's esophagus	0.00132	0.0151	CcSEcCtD
Epoprostenol—PTGIS—Prostaglandin Synthesis and Regulation—PTGS2—Barrett's esophagus	0.00112	0.0194	CbGpPWpGaD
Epoprostenol—Hepatic failure—Omeprazole—Barrett's esophagus	0.00107	0.0123	CcSEcCtD
Epoprostenol—Hepatic failure—Esomeprazole—Barrett's esophagus	0.00107	0.0123	CcSEcCtD
Epoprostenol—PTGIS—Biological oxidations—CYP26A1—Barrett's esophagus	0.00107	0.0185	CbGpPWpGaD
Epoprostenol—Thirst—Esomeprazole—Barrett's esophagus	0.00101	0.0116	CcSEcCtD
Epoprostenol—Thirst—Omeprazole—Barrett's esophagus	0.00101	0.0116	CcSEcCtD
Epoprostenol—PTGIS—Adipogenesis—BMP4—Barrett's esophagus	0.00101	0.0175	CbGpPWpGaD
Epoprostenol—Arthritis—Esomeprazole—Barrett's esophagus	0.000992	0.0114	CcSEcCtD
Epoprostenol—Arthritis—Omeprazole—Barrett's esophagus	0.000992	0.0114	CcSEcCtD
Epoprostenol—Gastritis—Esomeprazole—Barrett's esophagus	0.000853	0.00979	CcSEcCtD
Epoprostenol—Gastritis—Omeprazole—Barrett's esophagus	0.000853	0.00979	CcSEcCtD
Epoprostenol—Abdominal distension—Omeprazole—Barrett's esophagus	0.000839	0.00962	CcSEcCtD
Epoprostenol—Abdominal distension—Esomeprazole—Barrett's esophagus	0.000839	0.00962	CcSEcCtD
Epoprostenol—PTGIR—Prostaglandin Synthesis and Regulation—PTGS2—Barrett's esophagus	0.000816	0.0142	CbGpPWpGaD
Epoprostenol—PTGER1—Prostaglandin Synthesis and Regulation—PTGS2—Barrett's esophagus	0.000816	0.0142	CbGpPWpGaD
Epoprostenol—Pancytopenia—Esomeprazole—Barrett's esophagus	0.000791	0.00908	CcSEcCtD
Epoprostenol—Pancytopenia—Omeprazole—Barrett's esophagus	0.000791	0.00908	CcSEcCtD
Epoprostenol—Weight decreased—Omeprazole—Barrett's esophagus	0.000754	0.00865	CcSEcCtD
Epoprostenol—Weight decreased—Esomeprazole—Barrett's esophagus	0.000754	0.00865	CcSEcCtD
Epoprostenol—Infestation—Esomeprazole—Barrett's esophagus	0.000743	0.00852	CcSEcCtD
Epoprostenol—Infestation NOS—Omeprazole—Barrett's esophagus	0.000743	0.00852	CcSEcCtD
Epoprostenol—Infestation—Omeprazole—Barrett's esophagus	0.000743	0.00852	CcSEcCtD
Epoprostenol—Infestation NOS—Esomeprazole—Barrett's esophagus	0.000743	0.00852	CcSEcCtD
Epoprostenol—PTGIS—Arachidonic acid metabolism—PTGS2—Barrett's esophagus	0.000741	0.0129	CbGpPWpGaD
Epoprostenol—Depression—Esomeprazole—Barrett's esophagus	0.000741	0.0085	CcSEcCtD
Epoprostenol—Depression—Omeprazole—Barrett's esophagus	0.000741	0.0085	CcSEcCtD
Epoprostenol—Urinary tract infection—Omeprazole—Barrett's esophagus	0.000722	0.00828	CcSEcCtD
Epoprostenol—Urinary tract infection—Esomeprazole—Barrett's esophagus	0.000722	0.00828	CcSEcCtD
Epoprostenol—Haematuria—Esomeprazole—Barrett's esophagus	0.000708	0.00813	CcSEcCtD
Epoprostenol—Haematuria—Omeprazole—Barrett's esophagus	0.000708	0.00813	CcSEcCtD
Epoprostenol—Epistaxis—Esomeprazole—Barrett's esophagus	0.000701	0.00804	CcSEcCtD
Epoprostenol—Epistaxis—Omeprazole—Barrett's esophagus	0.000701	0.00804	CcSEcCtD
Epoprostenol—Sinusitis—Esomeprazole—Barrett's esophagus	0.000697	0.008	CcSEcCtD
Epoprostenol—Sinusitis—Omeprazole—Barrett's esophagus	0.000697	0.008	CcSEcCtD
Epoprostenol—PTGER1—G alpha (q) signalling events—GAST—Barrett's esophagus	0.000686	0.0119	CbGpPWpGaD
Epoprostenol—Bradycardia—Omeprazole—Barrett's esophagus	0.000679	0.00779	CcSEcCtD
Epoprostenol—Bradycardia—Esomeprazole—Barrett's esophagus	0.000679	0.00779	CcSEcCtD
Epoprostenol—Rhinitis—Omeprazole—Barrett's esophagus	0.000668	0.00767	CcSEcCtD
Epoprostenol—Rhinitis—Esomeprazole—Barrett's esophagus	0.000668	0.00767	CcSEcCtD
Epoprostenol—Hypoaesthesia—Esomeprazole—Barrett's esophagus	0.000663	0.00761	CcSEcCtD
Epoprostenol—Hypoaesthesia—Omeprazole—Barrett's esophagus	0.000663	0.00761	CcSEcCtD
Epoprostenol—Pharyngitis—Omeprazole—Barrett's esophagus	0.000662	0.00759	CcSEcCtD
Epoprostenol—Pharyngitis—Esomeprazole—Barrett's esophagus	0.000662	0.00759	CcSEcCtD
Epoprostenol—Oedema peripheral—Omeprazole—Barrett's esophagus	0.000657	0.00754	CcSEcCtD
Epoprostenol—Oedema peripheral—Esomeprazole—Barrett's esophagus	0.000657	0.00754	CcSEcCtD
Epoprostenol—Connective tissue disorder—Omeprazole—Barrett's esophagus	0.000655	0.00752	CcSEcCtD
Epoprostenol—Connective tissue disorder—Esomeprazole—Barrett's esophagus	0.000655	0.00752	CcSEcCtD
Epoprostenol—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—NR1I2—Barrett's esophagus	0.00063	0.0109	CbGpPWpGaD
Epoprostenol—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP26A1—Barrett's esophagus	0.00063	0.0109	CbGpPWpGaD
Epoprostenol—Flushing—Omeprazole—Barrett's esophagus	0.000619	0.0071	CcSEcCtD
Epoprostenol—Flushing—Esomeprazole—Barrett's esophagus	0.000619	0.0071	CcSEcCtD
Epoprostenol—PTGER1—Gastrin-CREB signalling pathway via PKC and MAPK—GAST—Barrett's esophagus	0.000613	0.0106	CbGpPWpGaD
Epoprostenol—CYP2C9—Arachidonic acid metabolism—PTGES—Barrett's esophagus	0.000611	0.0106	CbGpPWpGaD
Epoprostenol—Mediastinal disorder—Omeprazole—Barrett's esophagus	0.000601	0.0069	CcSEcCtD
Epoprostenol—Mediastinal disorder—Esomeprazole—Barrett's esophagus	0.000601	0.0069	CcSEcCtD
Epoprostenol—Chills—Esomeprazole—Barrett's esophagus	0.000598	0.00687	CcSEcCtD
Epoprostenol—Chills—Omeprazole—Barrett's esophagus	0.000598	0.00687	CcSEcCtD
Epoprostenol—Mental disorder—Esomeprazole—Barrett's esophagus	0.000584	0.0067	CcSEcCtD
Epoprostenol—Mental disorder—Omeprazole—Barrett's esophagus	0.000584	0.0067	CcSEcCtD
Epoprostenol—Flatulence—Esomeprazole—Barrett's esophagus	0.000572	0.00656	CcSEcCtD
Epoprostenol—Flatulence—Omeprazole—Barrett's esophagus	0.000572	0.00656	CcSEcCtD
Epoprostenol—Tension—Omeprazole—Barrett's esophagus	0.00057	0.00654	CcSEcCtD
Epoprostenol—Tension—Esomeprazole—Barrett's esophagus	0.00057	0.00654	CcSEcCtD
Epoprostenol—CYP2C9—digestive system—Barrett's esophagus	0.000567	0.0436	CbGeAlD
Epoprostenol—Nervousness—Esomeprazole—Barrett's esophagus	0.000564	0.00647	CcSEcCtD
Epoprostenol—Nervousness—Omeprazole—Barrett's esophagus	0.000564	0.00647	CcSEcCtD
Epoprostenol—Back pain—Omeprazole—Barrett's esophagus	0.000561	0.00644	CcSEcCtD
Epoprostenol—Back pain—Esomeprazole—Barrett's esophagus	0.000561	0.00644	CcSEcCtD
Epoprostenol—Muscle spasms—Esomeprazole—Barrett's esophagus	0.000558	0.0064	CcSEcCtD
Epoprostenol—Muscle spasms—Omeprazole—Barrett's esophagus	0.000558	0.0064	CcSEcCtD
Epoprostenol—Tremor—Omeprazole—Barrett's esophagus	0.000544	0.00624	CcSEcCtD
Epoprostenol—Tremor—Esomeprazole—Barrett's esophagus	0.000544	0.00624	CcSEcCtD
Epoprostenol—PTGIS—Metabolism of lipids and lipoproteins—PTGES—Barrett's esophagus	0.00054	0.00937	CbGpPWpGaD
Epoprostenol—Anaemia—Esomeprazole—Barrett's esophagus	0.000536	0.00616	CcSEcCtD
Epoprostenol—Anaemia—Omeprazole—Barrett's esophagus	0.000536	0.00616	CcSEcCtD
Epoprostenol—Agitation—Omeprazole—Barrett's esophagus	0.000533	0.00612	CcSEcCtD
Epoprostenol—Agitation—Esomeprazole—Barrett's esophagus	0.000533	0.00612	CcSEcCtD
Epoprostenol—Palpitations—Omeprazole—Barrett's esophagus	0.000513	0.00589	CcSEcCtD
Epoprostenol—Palpitations—Esomeprazole—Barrett's esophagus	0.000513	0.00589	CcSEcCtD
Epoprostenol—Cough—Esomeprazole—Barrett's esophagus	0.000506	0.00581	CcSEcCtD
Epoprostenol—Cough—Omeprazole—Barrett's esophagus	0.000506	0.00581	CcSEcCtD
Epoprostenol—Chest pain—Esomeprazole—Barrett's esophagus	0.000494	0.00567	CcSEcCtD
Epoprostenol—Myalgia—Esomeprazole—Barrett's esophagus	0.000494	0.00567	CcSEcCtD
Epoprostenol—Arthralgia—Omeprazole—Barrett's esophagus	0.000494	0.00567	CcSEcCtD
Epoprostenol—Chest pain—Omeprazole—Barrett's esophagus	0.000494	0.00567	CcSEcCtD
Epoprostenol—Myalgia—Omeprazole—Barrett's esophagus	0.000494	0.00567	CcSEcCtD
Epoprostenol—Arthralgia—Esomeprazole—Barrett's esophagus	0.000494	0.00567	CcSEcCtD
Epoprostenol—Anxiety—Esomeprazole—Barrett's esophagus	0.000492	0.00565	CcSEcCtD
Epoprostenol—Anxiety—Omeprazole—Barrett's esophagus	0.000492	0.00565	CcSEcCtD
Epoprostenol—Unspecified disorder of skin and subcutaneous tissue—Omeprazole—Barrett's esophagus	0.000491	0.00563	CcSEcCtD
Epoprostenol—Unspecified disorder of skin and subcutaneous tissue—Esomeprazole—Barrett's esophagus	0.000491	0.00563	CcSEcCtD
Epoprostenol—Dry mouth—Esomeprazole—Barrett's esophagus	0.000483	0.00555	CcSEcCtD
Epoprostenol—Dry mouth—Omeprazole—Barrett's esophagus	0.000483	0.00555	CcSEcCtD
Epoprostenol—Confusional state—Omeprazole—Barrett's esophagus	0.000478	0.00548	CcSEcCtD
Epoprostenol—Confusional state—Esomeprazole—Barrett's esophagus	0.000478	0.00548	CcSEcCtD
Epoprostenol—PTGIS—Defective AMN causes hereditary megaloblastic anemia 1—PTGS2—Barrett's esophagus	0.000476	0.00826	CbGpPWpGaD
Epoprostenol—Anaphylactic shock—Esomeprazole—Barrett's esophagus	0.000474	0.00544	CcSEcCtD
Epoprostenol—Anaphylactic shock—Omeprazole—Barrett's esophagus	0.000474	0.00544	CcSEcCtD
Epoprostenol—Infection—Esomeprazole—Barrett's esophagus	0.000471	0.0054	CcSEcCtD
Epoprostenol—Infection—Omeprazole—Barrett's esophagus	0.000471	0.0054	CcSEcCtD
Epoprostenol—Shock—Omeprazole—Barrett's esophagus	0.000466	0.00535	CcSEcCtD
Epoprostenol—Shock—Esomeprazole—Barrett's esophagus	0.000466	0.00535	CcSEcCtD
Epoprostenol—Nervous system disorder—Esomeprazole—Barrett's esophagus	0.000465	0.00533	CcSEcCtD
Epoprostenol—Nervous system disorder—Omeprazole—Barrett's esophagus	0.000465	0.00533	CcSEcCtD
Epoprostenol—Thrombocytopenia—Esomeprazole—Barrett's esophagus	0.000464	0.00532	CcSEcCtD
Epoprostenol—Thrombocytopenia—Omeprazole—Barrett's esophagus	0.000464	0.00532	CcSEcCtD
Epoprostenol—Tachycardia—Omeprazole—Barrett's esophagus	0.000462	0.00531	CcSEcCtD
Epoprostenol—Tachycardia—Esomeprazole—Barrett's esophagus	0.000462	0.00531	CcSEcCtD
Epoprostenol—Skin disorder—Esomeprazole—Barrett's esophagus	0.00046	0.00528	CcSEcCtD
Epoprostenol—Skin disorder—Omeprazole—Barrett's esophagus	0.00046	0.00528	CcSEcCtD
Epoprostenol—Hyperhidrosis—Esomeprazole—Barrett's esophagus	0.000458	0.00525	CcSEcCtD
Epoprostenol—Hyperhidrosis—Omeprazole—Barrett's esophagus	0.000458	0.00525	CcSEcCtD
Epoprostenol—Anorexia—Omeprazole—Barrett's esophagus	0.000452	0.00518	CcSEcCtD
Epoprostenol—Anorexia—Esomeprazole—Barrett's esophagus	0.000452	0.00518	CcSEcCtD
Epoprostenol—PTGIS—Adipogenesis—PPARG—Barrett's esophagus	0.000439	0.00761	CbGpPWpGaD
Epoprostenol—Musculoskeletal discomfort—Esomeprazole—Barrett's esophagus	0.000432	0.00495	CcSEcCtD
Epoprostenol—Musculoskeletal discomfort—Omeprazole—Barrett's esophagus	0.000432	0.00495	CcSEcCtD
Epoprostenol—Insomnia—Omeprazole—Barrett's esophagus	0.000428	0.00492	CcSEcCtD
Epoprostenol—Insomnia—Esomeprazole—Barrett's esophagus	0.000428	0.00492	CcSEcCtD
Epoprostenol—P2RY12—G alpha (i) signalling events—SST—Barrett's esophagus	0.000425	0.00738	CbGpPWpGaD
Epoprostenol—Paraesthesia—Omeprazole—Barrett's esophagus	0.000425	0.00488	CcSEcCtD
Epoprostenol—Paraesthesia—Esomeprazole—Barrett's esophagus	0.000425	0.00488	CcSEcCtD
Epoprostenol—Dyspnoea—Omeprazole—Barrett's esophagus	0.000422	0.00485	CcSEcCtD
Epoprostenol—Dyspnoea—Esomeprazole—Barrett's esophagus	0.000422	0.00485	CcSEcCtD
Epoprostenol—Somnolence—Omeprazole—Barrett's esophagus	0.000421	0.00483	CcSEcCtD
Epoprostenol—Somnolence—Esomeprazole—Barrett's esophagus	0.000421	0.00483	CcSEcCtD
Epoprostenol—Dyspepsia—Omeprazole—Barrett's esophagus	0.000417	0.00478	CcSEcCtD
Epoprostenol—Dyspepsia—Esomeprazole—Barrett's esophagus	0.000417	0.00478	CcSEcCtD
Epoprostenol—Decreased appetite—Omeprazole—Barrett's esophagus	0.000412	0.00473	CcSEcCtD
Epoprostenol—Decreased appetite—Esomeprazole—Barrett's esophagus	0.000412	0.00473	CcSEcCtD
Epoprostenol—Gastrointestinal disorder—Esomeprazole—Barrett's esophagus	0.000409	0.00469	CcSEcCtD
Epoprostenol—Gastrointestinal disorder—Omeprazole—Barrett's esophagus	0.000409	0.00469	CcSEcCtD
Epoprostenol—Fatigue—Esomeprazole—Barrett's esophagus	0.000408	0.00469	CcSEcCtD
Epoprostenol—Fatigue—Omeprazole—Barrett's esophagus	0.000408	0.00469	CcSEcCtD
Epoprostenol—Constipation—Omeprazole—Barrett's esophagus	0.000405	0.00465	CcSEcCtD
Epoprostenol—Pain—Esomeprazole—Barrett's esophagus	0.000405	0.00465	CcSEcCtD
Epoprostenol—Constipation—Esomeprazole—Barrett's esophagus	0.000405	0.00465	CcSEcCtD
Epoprostenol—Pain—Omeprazole—Barrett's esophagus	0.000405	0.00465	CcSEcCtD
Epoprostenol—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP26A1—Barrett's esophagus	0.0004	0.00694	CbGpPWpGaD
Epoprostenol—CYP2C9—Oxidation by Cytochrome P450—CYP26A1—Barrett's esophagus	0.000395	0.00685	CbGpPWpGaD
Epoprostenol—Gastrointestinal pain—Esomeprazole—Barrett's esophagus	0.000387	0.00444	CcSEcCtD
Epoprostenol—Gastrointestinal pain—Omeprazole—Barrett's esophagus	0.000387	0.00444	CcSEcCtD
Epoprostenol—Urticaria—Omeprazole—Barrett's esophagus	0.000376	0.00432	CcSEcCtD
Epoprostenol—Urticaria—Esomeprazole—Barrett's esophagus	0.000376	0.00432	CcSEcCtD
Epoprostenol—Abdominal pain—Omeprazole—Barrett's esophagus	0.000374	0.0043	CcSEcCtD
Epoprostenol—Body temperature increased—Omeprazole—Barrett's esophagus	0.000374	0.0043	CcSEcCtD
Epoprostenol—Abdominal pain—Esomeprazole—Barrett's esophagus	0.000374	0.0043	CcSEcCtD
Epoprostenol—Body temperature increased—Esomeprazole—Barrett's esophagus	0.000374	0.0043	CcSEcCtD
Epoprostenol—Hypersensitivity—Omeprazole—Barrett's esophagus	0.000349	0.004	CcSEcCtD
Epoprostenol—Hypersensitivity—Esomeprazole—Barrett's esophagus	0.000349	0.004	CcSEcCtD
Epoprostenol—Asthenia—Omeprazole—Barrett's esophagus	0.00034	0.0039	CcSEcCtD
Epoprostenol—Asthenia—Esomeprazole—Barrett's esophagus	0.00034	0.0039	CcSEcCtD
Epoprostenol—P2RY12—Class A/1 (Rhodopsin-like receptors)—SST—Barrett's esophagus	0.000338	0.00587	CbGpPWpGaD
Epoprostenol—Pruritus—Esomeprazole—Barrett's esophagus	0.000335	0.00385	CcSEcCtD
Epoprostenol—Pruritus—Omeprazole—Barrett's esophagus	0.000335	0.00385	CcSEcCtD
Epoprostenol—CYP2C9—Phase 1 - Functionalization of compounds—CYP26A1—Barrett's esophagus	0.000324	0.00563	CbGpPWpGaD
Epoprostenol—Diarrhoea—Omeprazole—Barrett's esophagus	0.000324	0.00372	CcSEcCtD
Epoprostenol—Diarrhoea—Esomeprazole—Barrett's esophagus	0.000324	0.00372	CcSEcCtD
Epoprostenol—P2RY12—Platelet activation, signaling and aggregation—HGF—Barrett's esophagus	0.000318	0.00553	CbGpPWpGaD
Epoprostenol—Dizziness—Esomeprazole—Barrett's esophagus	0.000313	0.00359	CcSEcCtD
Epoprostenol—Dizziness—Omeprazole—Barrett's esophagus	0.000313	0.00359	CcSEcCtD
Epoprostenol—PTGER1—Class A/1 (Rhodopsin-like receptors)—SST—Barrett's esophagus	0.000311	0.0054	CbGpPWpGaD
Epoprostenol—PTGIR—Class A/1 (Rhodopsin-like receptors)—SST—Barrett's esophagus	0.000311	0.0054	CbGpPWpGaD
Epoprostenol—Vomiting—Esomeprazole—Barrett's esophagus	0.000301	0.00346	CcSEcCtD
Epoprostenol—Vomiting—Omeprazole—Barrett's esophagus	0.000301	0.00346	CcSEcCtD
Epoprostenol—Rash—Omeprazole—Barrett's esophagus	0.000299	0.00343	CcSEcCtD
Epoprostenol—Rash—Esomeprazole—Barrett's esophagus	0.000299	0.00343	CcSEcCtD
Epoprostenol—Dermatitis—Omeprazole—Barrett's esophagus	0.000298	0.00342	CcSEcCtD
Epoprostenol—Dermatitis—Esomeprazole—Barrett's esophagus	0.000298	0.00342	CcSEcCtD
Epoprostenol—Headache—Omeprazole—Barrett's esophagus	0.000297	0.00341	CcSEcCtD
Epoprostenol—Headache—Esomeprazole—Barrett's esophagus	0.000297	0.00341	CcSEcCtD
Epoprostenol—Nausea—Esomeprazole—Barrett's esophagus	0.000281	0.00323	CcSEcCtD
Epoprostenol—Nausea—Omeprazole—Barrett's esophagus	0.000281	0.00323	CcSEcCtD
Epoprostenol—P2RY12—GPCR ligand binding—SST—Barrett's esophagus	0.000258	0.00447	CbGpPWpGaD
Epoprostenol—PTGIS—Metabolism—PTGES—Barrett's esophagus	0.00024	0.00417	CbGpPWpGaD
Epoprostenol—PTGER1—GPCR ligand binding—SST—Barrett's esophagus	0.000237	0.00411	CbGpPWpGaD
Epoprostenol—PTGIR—GPCR ligand binding—SST—Barrett's esophagus	0.000237	0.00411	CbGpPWpGaD
Epoprostenol—P2RY12—GPCR downstream signaling—GAST—Barrett's esophagus	0.000212	0.00369	CbGpPWpGaD
Epoprostenol—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—Barrett's esophagus	0.000207	0.0036	CbGpPWpGaD
Epoprostenol—PTGIR—GPCR downstream signaling—GAST—Barrett's esophagus	0.000195	0.00339	CbGpPWpGaD
Epoprostenol—PTGER1—GPCR downstream signaling—GAST—Barrett's esophagus	0.000195	0.00339	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling by GPCR—GAST—Barrett's esophagus	0.000193	0.00335	CbGpPWpGaD
Epoprostenol—PTGIS—Metabolism—CYP26A1—Barrett's esophagus	0.000182	0.00316	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling by GPCR—GAST—Barrett's esophagus	0.000178	0.00308	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling by GPCR—GAST—Barrett's esophagus	0.000178	0.00308	CbGpPWpGaD
Epoprostenol—CYP2C9—Biological oxidations—CYP26A1—Barrett's esophagus	0.000172	0.00299	CbGpPWpGaD
Epoprostenol—CYP2C9—Metapathway biotransformation—CYP26A1—Barrett's esophagus	0.00017	0.00295	CbGpPWpGaD
Epoprostenol—P2RY12—G alpha (i) signalling events—CXCL8—Barrett's esophagus	0.000166	0.00288	CbGpPWpGaD
Epoprostenol—P2RY12—Hemostasis—HGF—Barrett's esophagus	0.000164	0.00285	CbGpPWpGaD
Epoprostenol—PTGIS—Disease—SLC9A1—Barrett's esophagus	0.000157	0.00272	CbGpPWpGaD
Epoprostenol—PTGIR—Hemostasis—HGF—Barrett's esophagus	0.000151	0.00262	CbGpPWpGaD
Epoprostenol—P2RY12—GPCR downstream signaling—SST—Barrett's esophagus	0.000146	0.00253	CbGpPWpGaD
Epoprostenol—PTGIS—Metabolism of lipids and lipoproteins—PPARG—Barrett's esophagus	0.000135	0.00234	CbGpPWpGaD
Epoprostenol—PTGIR—GPCR downstream signaling—SST—Barrett's esophagus	0.000134	0.00233	CbGpPWpGaD
Epoprostenol—PTGER1—GPCR downstream signaling—SST—Barrett's esophagus	0.000134	0.00233	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling by GPCR—SST—Barrett's esophagus	0.000132	0.00229	CbGpPWpGaD
Epoprostenol—P2RY12—Class A/1 (Rhodopsin-like receptors)—CXCL8—Barrett's esophagus	0.000132	0.00229	CbGpPWpGaD
Epoprostenol—PTGIS—Metabolism—SLC9A1—Barrett's esophagus	0.000131	0.00228	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling by GPCR—SST—Barrett's esophagus	0.000122	0.00211	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling by GPCR—SST—Barrett's esophagus	0.000122	0.00211	CbGpPWpGaD
Epoprostenol—PTGER1—Class A/1 (Rhodopsin-like receptors)—CXCL8—Barrett's esophagus	0.000121	0.00211	CbGpPWpGaD
Epoprostenol—PTGIR—Class A/1 (Rhodopsin-like receptors)—CXCL8—Barrett's esophagus	0.000121	0.00211	CbGpPWpGaD
Epoprostenol—CYP2C9—Arachidonic acid metabolism—PTGS2—Barrett's esophagus	0.00012	0.00208	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling Pathways—GAST—Barrett's esophagus	0.000114	0.00198	CbGpPWpGaD
Epoprostenol—PTGIS—Metabolism of lipids and lipoproteins—PTGS2—Barrett's esophagus	0.000106	0.00184	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling Pathways—GAST—Barrett's esophagus	0.000105	0.00182	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling Pathways—GAST—Barrett's esophagus	0.000105	0.00182	CbGpPWpGaD
Epoprostenol—P2RY12—GPCR ligand binding—CXCL8—Barrett's esophagus	0.0001	0.00174	CbGpPWpGaD
Epoprostenol—PTGIR—GPCR ligand binding—CXCL8—Barrett's esophagus	9.24e-05	0.0016	CbGpPWpGaD
Epoprostenol—PTGER1—GPCR ligand binding—CXCL8—Barrett's esophagus	9.24e-05	0.0016	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism of lipids and lipoproteins—PTGES—Barrett's esophagus	8.73e-05	0.00151	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling Pathways—SST—Barrett's esophagus	7.81e-05	0.00136	CbGpPWpGaD
Epoprostenol—PTGIS—Disease—APC—Barrett's esophagus	7.42e-05	0.00129	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling Pathways—SST—Barrett's esophagus	7.19e-05	0.00125	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling Pathways—SST—Barrett's esophagus	7.19e-05	0.00125	CbGpPWpGaD
Epoprostenol—PTGIS—Metabolism—PPARG—Barrett's esophagus	6e-05	0.00104	CbGpPWpGaD
Epoprostenol—P2RY12—GPCR downstream signaling—CXCL8—Barrett's esophagus	5.67e-05	0.000984	CbGpPWpGaD
Epoprostenol—PTGIS—Disease—PTGS2—Barrett's esophagus	5.63e-05	0.000978	CbGpPWpGaD
Epoprostenol—P2RY12—Hemostasis—TP53—Barrett's esophagus	5.51e-05	0.000956	CbGpPWpGaD
Epoprostenol—PTGIR—GPCR downstream signaling—CXCL8—Barrett's esophagus	5.22e-05	0.000906	CbGpPWpGaD
Epoprostenol—PTGER1—GPCR downstream signaling—CXCL8—Barrett's esophagus	5.22e-05	0.000906	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling by GPCR—CXCL8—Barrett's esophagus	5.15e-05	0.000894	CbGpPWpGaD
Epoprostenol—PTGIR—Hemostasis—TP53—Barrett's esophagus	5.07e-05	0.00088	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling by GPCR—CXCL8—Barrett's esophagus	4.74e-05	0.000823	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling by GPCR—CXCL8—Barrett's esophagus	4.74e-05	0.000823	CbGpPWpGaD
Epoprostenol—PTGIS—Metabolism—PTGS2—Barrett's esophagus	4.72e-05	0.000819	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling Pathways—APC—Barrett's esophagus	4.13e-05	0.000717	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism—PTGES—Barrett's esophagus	3.89e-05	0.000674	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling Pathways—APC—Barrett's esophagus	3.8e-05	0.00066	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling Pathways—APC—Barrett's esophagus	3.8e-05	0.00066	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling Pathways—RELA—Barrett's esophagus	3.23e-05	0.00056	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling Pathways—CXCL8—Barrett's esophagus	3.04e-05	0.000528	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling Pathways—RELA—Barrett's esophagus	2.97e-05	0.000516	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling Pathways—RELA—Barrett's esophagus	2.97e-05	0.000516	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism—CYP26A1—Barrett's esophagus	2.94e-05	0.000511	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling Pathways—CXCL8—Barrett's esophagus	2.8e-05	0.000486	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling Pathways—CXCL8—Barrett's esophagus	2.8e-05	0.000486	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—Barrett's esophagus	2.18e-05	0.000378	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism—SLC9A1—Barrett's esophagus	2.12e-05	0.000368	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling Pathways—TP53—Barrett's esophagus	1.87e-05	0.000324	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling Pathways—TP53—Barrett's esophagus	1.72e-05	0.000298	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling Pathways—TP53—Barrett's esophagus	1.72e-05	0.000298	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—Barrett's esophagus	1.71e-05	0.000297	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism—PPARG—Barrett's esophagus	9.69e-06	0.000168	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism—PTGS2—Barrett's esophagus	7.62e-06	0.000132	CbGpPWpGaD
